180 related articles for article (PubMed ID: 29483302)
41. IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling.
Yoneyama Y; Lanzerstorfer P; Niwa H; Umehara T; Shibano T; Yokoyama S; Chida K; Weghuber J; Hakuno F; Takahashi SI
Elife; 2018 Apr; 7():. PubMed ID: 29661273
[TBL] [Abstract][Full Text] [Related]
42. Signal transduction mechanism of insulin and insulin-like growth factor-1.
Kadowaki T; Tobe K; Honda-Yamamoto R; Tamemoto H; Kaburagi Y; Momomura K; Ueki K; Takahashi Y; Yamauchi T; Akanuma Y; Yazaki Y
Endocr J; 1996 Oct; 43 Suppl():S33-41. PubMed ID: 9076340
[TBL] [Abstract][Full Text] [Related]
43. Ethanol inhibits insulin-like growth factor-1-mediated signalling and proliferation of C6 rat glioblastoma cells.
Resnicoff M; Rubini M; Baserga R; Rubin R
Lab Invest; 1994 Nov; 71(5):657-62. PubMed ID: 7526037
[TBL] [Abstract][Full Text] [Related]
44. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
45. Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination.
Trojanek J; Ho T; Del Valle L; Nowicki M; Wang JY; Lassak A; Peruzzi F; Khalili K; Skorski T; Reiss K
Mol Cell Biol; 2003 Nov; 23(21):7510-24. PubMed ID: 14559999
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
47. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
48. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
Rui L; Fisher TL; Thomas J; White MF
J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773
[TBL] [Abstract][Full Text] [Related]
49. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
50. Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts.
Winnay JN; Brüning JC; Burks DJ; Kahn CR
J Biol Chem; 2000 Apr; 275(14):10545-50. PubMed ID: 10744748
[TBL] [Abstract][Full Text] [Related]
51. Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis.
Tu X; Batta P; Innocent N; Prisco M; Casaburi I; Belletti B; Baserga R
J Biol Chem; 2002 Nov; 277(46):44357-65. PubMed ID: 12202493
[TBL] [Abstract][Full Text] [Related]
52. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
53. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation.
Gorgisen G; Gulacar IM; Ozes ON
Cell Mol Biol (Noisy-le-grand); 2017 Jan; 63(1):1-5. PubMed ID: 28234626
[TBL] [Abstract][Full Text] [Related]
54. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
[TBL] [Abstract][Full Text] [Related]
55. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
56. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
57. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
58. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
Satoh S; Yanagita T; Maruta T; Nemoto T; Yoshikawa N; Kobayashi H; Tono T; Wada A
Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359
[TBL] [Abstract][Full Text] [Related]
59. Hexachlorobenzene is a tumor co-carcinogen and induces alterations in insulin-growth factors signaling pathway in the rat mammary gland.
Randi AS; Cocca C; Carbone V; Nuñez M; Croci M; Gutiérrez A; Bergoc R; Kleiman de Pisarev DL
Toxicol Sci; 2006 Jan; 89(1):83-92. PubMed ID: 16237195
[TBL] [Abstract][Full Text] [Related]
60. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases.
Dews M; Prisco M; Peruzzi F; Romano G; Morrione A; Baserga R
Endocrinology; 2000 Apr; 141(4):1289-300. PubMed ID: 10746631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
